Aurora Cannabis Inc. announced an expansion of its medical compassionate pricing program in Canada, increasing the yearly income eligibility from $40,000 to $60,000 CAD for patients accessing products through AuroraMedical.com. This move is part of the company's ongoing commitment to making medical cannabis more accessible.
The expanded eligibility aims to reduce financial barriers for a broader segment of the Canadian patient population who rely on medical cannabis. This program reinforces Aurora's patient-first approach and its dedication to supporting the medical cannabis community.
By offering a more inclusive pricing program, Aurora seeks to grow its domestic patient base while upholding its reputation as a leading provider of high-quality medical cannabis in Canada.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.